Balancing commercial and public interests

Unanswered ethical and scientific questions for trials of invasive interventions for coronary disease: The case of single vessel disease

Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran

Current trends in the cardiovascular clinical trial arena (I)

Informative noncompliance in endpoint trials

Individualizing therapy – in search of approaches to maximize the benefit of drug treatment (II)

Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)

A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases

A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]

Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study

Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial)